Brain Monoamines in Cerebral Ischemic Edema, the Effect of Gamma-Hydroxy-Butyrate

  • C. Maruki
  • N. Merkel
  • W. D. Rausch
  • M. Spatz


The ischemically induced disturbances of monoamines metabolism may persist longer than those of energy metabolism3,4. Among the observed changes in the monoamines of the brain, the reduction of the 5-hydroxytryptamine (5-HT) levels correlated best with the formation of ischemic edema induced in gerbils by 15 minutes of bilateral common carotid artery occlusion and release9. This type of brain edema was ameliorated by treatment with γ-hydroxybutyrate (GHB) or its metabolite γ-butyrolactone (GBL)1. Both of these substances belong to the naturally occurring central nervous system depressants which affect various cerebral metabolic pathways including those of the neurotransmitters when given to normal animals14,18. In the gerbil model of ischemia, they were found not only to reduce the progression of edema but to spare the energy metabolism and increase the survival rate of the affected animals. Moreover, correlative studies showed that the GHB or GBL treatment was of greater benefit than hypothermia or pentobarbital1,13,15 Since the overall advantages of GHB or GBL could not be entirely explained on the basis of hypometabolism, which is the common denominator for each of these therapeutic agents19, we investigated the GHB effect on the cerebral monoamines in ischemic cerebral edema.


Tyrosine Hydroxylase High Pressure Liquid Chromatography Brain Edema Tryptophan Hydroxylase Bilateral Common Carotid Artery Occlusion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Abe K, Abe T, Klatzo I, Spatz M: Effects of endogenous central nervous system depressants in ischemic cerebral edema of gerbils. Adv Neurol 28: 429–441 (1980).Google Scholar
  2. 2.
    Bioanalytic Systems, Inc.: Tissue catecholamines; Plasma cat-echolamines. LCEC application notes no. 12 and 14, respectively.Google Scholar
  3. 3.
    Cvejic V, Djuricic BM, Mrsulja BB: Oscillatory pattern of cat-echolamine metabolism following transient cerebral ischemia in gerbils. In: Circulatory and developmental aspects of brain metabolism, Spatz M, Mrsulja BB, Rakic Lj, Lust WD (Eds.). Plenum Press, New York 97–102 (1980).CrossRefGoogle Scholar
  4. 4.
    Cvejic V, Micic DV, Djuricic BM, Mrsulja BJ, Mrsulja BB: Mono-amines and related enzymes in cerebral cortex and basal ganglia following transient ischemia in gerbils. Acta Neuropath 51: 71–77 (1980).CrossRefGoogle Scholar
  5. 5.
    Dienel GA, Pulsinelli WA, Duffy DE: Regional protein synthesis in rat brain following acute hemispheric ischemia. J Neurochem 35: 1216–1226 (1980).CrossRefGoogle Scholar
  6. 6.
    Kuhn DM, Ruskin D, Lowenberg W: Tryptophan hydroxylase. The role of oxygen, iron and sulfhydryl groups as determinants of stability and catalytic activity. J Biol Chem 255: 4137–4143 (1980).Google Scholar
  7. 7.
    McGeer EG, Gibson S, McGeer PL: Some characteristics of brain tyrosine hydroxylase. Can J Biochem 45: 1557–1563 (1967).CrossRefGoogle Scholar
  8. 8.
    Mrsulja BB, Mrsulja BJ, Spatz M, Klatzo I: Action of cerebral ischemia on decreased levels of 3-methoxy-4 hydroxyphenethyl-glycol sulphate, homovanillic acid and 5-hydroxyindolacetic acid produced by pargyline. Brain Res 98: 388–393 (1975).CrossRefGoogle Scholar
  9. 9.
    Mrsulja BB, Djuricic BM, Cvejic V, Mrsulja BJ, Abe K, Spatz M, Klatzo I: Biochemistry of experimental ischemic brain edema. In: Brain Edema, Cervos-Navarro J, Ferszt R (Eds.), Raven Press, New York, Adv Neurol 28: 429–441 (1980).Google Scholar
  10. 10.
    Persson B, Henning M: Central cardiovascular effects of gamma-hydroxybutyric acid: Interactions with noradrenaline, serotonin, dopamine and acetylcholine transmission. Acta Pharmacol Toxicol 47: 335–346 (1980).CrossRefGoogle Scholar
  11. 11.
    Reinhard JF Jr, Moskowitz MA, Sved AF, Fernstrom JD: A simple, sensitive and reliable assay for serotonin and 5-HIAA in brain tissue using liquid chromatography with electrochemical detection. Life Sci 27: 905–911 (1980).CrossRefGoogle Scholar
  12. 12.
    Shiman R, Akino M, Kaufman S: Solubilization and partial purification of tyrosine hydroxylase from bovine adrenal medulla. J Biol Chem 346: 1330–1340 (1971).Google Scholar
  13. 13.
    Smialek M, Klatzo I, Spatz M: the therapeutic effects on experimental cerebral ischemia in Mongolian gerbils. In: Cerebral vascular disease 2, Meyer JS, Lechner H, Reivich M (Eds.) Excerpta Medica, Amsterdam 186–192 (1979).Google Scholar
  14. 14.
    Snead OC, III: Minireview: Gamma hydroxybutyrate. Life Sci 20: 1935–1944 (1977).CrossRefGoogle Scholar
  15. 15.
    Spatz M, Abe K, Smialek M, Abe T:Evaluation of gamma hydroxybutyrate treatment in experimental cerebral ischemia. In: Pathophysiology and pharmacotherapy of Cerebrovascular disorders, Betz E, Grote J, Heuser D, Wüllenweber R (Eds.) Verlag Gerhard Witzstrock, Baden-Baden-KöIn-New York 286–289 (1980).Google Scholar
  16. 16.
    Sperk G: Simultaneous determination of serotonin, 5-hydroxy-indoleacetic acid, 3,4-dihydroxyphenylacetic acid and homo-vanillic acid by high performance liquid chromatography with electrochemical detection. J Neurochem 38: 840–843 (1982).CrossRefGoogle Scholar
  17. 17.
    Sved A, Fernstrom J: Tyrosine availability and dopamine synthesis in the striatum. Life Sci 29: 743–748 (1981).CrossRefGoogle Scholar
  18. 18.
    Walters JR, Roth RH: γ-Hydroxybutyrate: Considerations of endogenous role and therapeutic potential. In: Neuroregulators and psychiatric disorders, Usdin E, et al (Eds.) Oxford university press, New York 403–415 (1977).Google Scholar
  19. 19.
    Wolfson LI, Sakurada O, Sokoloff L: Effects of gammabutyrolac-tone on local glucose utilization in the rat. J Neurochem 29: 777–783 (1977).CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • C. Maruki
    • 1
  • N. Merkel
    • 1
  • W. D. Rausch
    • 1
  • M. Spatz
    • 1
  1. 1.Laboratory of Neuropathology and Neuroanatomical Sciences, National Institute of Neurological and Communicative Disorders and StrokeNational Institutes of HealthBethesdaUSA

Personalised recommendations